Health Matters: Our Microbiome Is Key
Dr. Irah King describes the role our microbiome plays in our overall health on the MUHC Foundation’s Health Matters.
Irah King
View his faculty profile here: Irah King, PhD
Associate Professor, Department of Microbiology and Immunology, Department of Medicine, McGill University
Research Theme: Immunity at barrier sites such as the lung, gut, and skin
Keywords: infectious disease • barrier tissue immunity • gut-lung axis • leukocyte migration • microbiome
View Irah King’s recent posts and news below.
RI-MUHC Gnotobiotic Research Platform
The RI-MUHC Gnotobiotic Research Platform is now open under the leadership of Dr. Irah King of the Meakins-Christie Labs.
Allergic Disease on the Rise
Increasing rate of allergic asthma looked at by McGill researchers, including Dr. Irah King.
COVID-19 and Disease Tolerance
Dr. Irah King discusses disease tolerance in light of the recent COVID-19 pandemic and why some weather the infection unscathed
Covid-19 in the gastrointestinal tract
Journalist Alexandre Touchette speaks with Dr. Irah King on COVID-19 GI symptoms.
Meakins faculty delegation to Braunschweig
Meakins faculty visit the Helmholtz Centre for Infection Research in Braunschweig
MI4 Gnotobiotic Animal Research Platform
Dr. Irah King announces the launch phase for the MI4 Gnotobiotic Animal Research Platform
Quebec Microbiome Research Symposium
Dr. Irah King organized the first Quebec Microbiome Research Symposium
Anti-TB drugs can increase risk of TB re-infection
Vulnerability of the host to Mycobacterium tuberculosis infection is due to a compromised gut microbiota
- « Previous
- 1
- 2